| abstract |
This invention provides compounds of Formula (I) wherein Ar is (a), (b) or (c). A, B, C, D, E, X, Y, Z1 and Z2 are as defined in the description, or a pharmaceutically acceptable salt thereof, which are useful in treating metabolic disorders related to insulin resistance or hyperglycemia. |